drugset
drugset / Trial / NCT05768204

Research on the Treatment of Severe Community-acquired Pneumonia in Children

NCT05768204 ↗

Phase 4 Unknown 160 enrolled Baoping XU
RandomizedParallel-groupTriple-blindTreatment

Summary

The need for glucocorticoid therapy in children with severe community-acquired pneumonia in the acute phase of the disease remains unclear. The implementation of this study could provide strong evidence on the need for adjuvant glucose therapy in children with severe community-acquired pneumonia.

Timeline

Start
2023-03-10
Primary completion
2025-12-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 2 mg/kg Oral

Indications

pneumonia